London, United Kingdom

Bertrand V Georges

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 1.4

ph-index = 3

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Bertrand V Georges

Introduction

Bertrand V Georges is a notable inventor based in London, GB, recognized for his significant contributions to the field of immunology. With a total of five patents to his name, he has made strides in developing advanced solutions for antigen delivery and immunostimulatory compounds.

Latest Patents

Georges' latest patents include innovative technologies such as antigen delivery vectors and constructs. This invention relates to fluorocarbon vectors designed for the effective delivery of antigens to immunoresponsive target cells. Additionally, he has developed immunogenic compounds that comprise an immunostimulant portion and a peptide portion. The peptide portion is characterized by having 75% or less of the amino acid residues as hydrophobic and an isoelectric point of 5 or greater. These compounds aim to address the systemic distribution of immunostimulants, which can lead to unwanted side effects.

Career Highlights

Throughout his career, Bertrand V Georges has worked with various companies, including Altimmune UK Limited and Immune Targeting Systems Ltd. His work has focused on creating innovative solutions that enhance the efficacy of vaccines and immunotherapeutics in animals.

Collaborations

Georges has collaborated with notable individuals in his field, including Dominique Bonnet and Philip J Sizer. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

In summary, Bertrand V Georges is a distinguished inventor whose work in immunology has led to the development of groundbreaking technologies. His contributions continue to impact the field positively, paving the way for future innovations in vaccine and immunotherapy development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…